Pregled bibliografske jedinice broj: 831441
Dipeptidyl peptidase−4 activity is associated with urine albumin excretion in type 1 diabetes
Dipeptidyl peptidase−4 activity is associated with urine albumin excretion in type 1 diabetes // Journal of diabetes and its complications, 31 (2016), 1; 218-222 doi:10.1016/j.jdiacomp.2016.08.022 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 831441 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Dipeptidyl peptidase−4 activity is associated with urine albumin excretion in type 1 diabetes
Autori
Duvnjak, Lea ; Nikolac Perković, Matea ; Blaslov, Kristina
Izvornik
Journal of diabetes and its complications (1056-8727) 31
(2016), 1;
218-222
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
albuminuria ; dipepidyl peptidase-4 ; type 1 diabetes mellitus ; diabetic kidney disease
Sažetak
The inability of kidneys to prevent urinary protein leakage represents the earliest sign of renal damage in diabetic kidney disease (DKD). Recent data suggest the possible nephroprotective role of the dipeptidyl peptidase-4 (DPP-4) inhibitors. We aimed to investigate whether serum DPP-4 activity is associated with urine albumin excretion (UAE) in patients with type 1 diabetes (type 1 DM). DPP-4 activity and UAE measurement were performed in 113 patients with type 1 DM and glomerular filtration rate (GFR) within normal range. They were divided into three groups according to UAE tertiles. Worse lipid profile and higher waist circumference were observed in the group with highest DPP-4 activity. Patients within lowest UAE tertile group had lowest DPP-4 activity value (p < 0.001) compared to group within second and third tertile of UAE. DPP-4 activity correlated with systolic blood pressure (ρ = 0.142 ; p = 0.001), HbA1c (ρ = 0.133 ; p = 0.013) and UAE (ρ = 0.349 ; p < 0.001). In the linear regression analysis when DPP-4 activity was adjusted for age, gender, disease duration, HbA1c, waist circumference, the use of ACEI and hypolipemic agents the association remained significant ; UAE increased for 8.136 mg/24 h by each increase of DPP-4 activity of 1 U/L (p < 0.008). Our results indicate that serum DPP-4 activity is associated with albuminuria in type 1 diabetes. This arises the question whether the use of DPP-4 inhibitors might serve as an additional therapeutic strategy to prevent proteinuria in patients with DKD.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE